Background and Objective: While a number of conditions and risk factors that increase stroke risk have been identified, arterial hypertension is the most consistent and powerful predictor.

New research reveals the potential of drugs that have been on the market for decades to treat diseases other than those for ...

Dysgeusia is an uncommonly reported side effect associated with angiotensin-converting enzyme inhibitors (ACE inhibitors). [1] The onset is almost always within the first 3 months and is ...

ArbliTM is the first FDA-approved ready-to-use oral liquid formulation of losartan, designed for treating hypertension and related conditions in patients over six years old. This novel product ...